4//SEC Filing
Piekos Brian 4
Accession 0001209191-22-033719
CIK 0001816736other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 7:14 PM ET
Size
5.0 KB
Accession
0001209191-22-033719
Insider Transaction Report
Form 4
Piekos Brian
Chief Financial Officer
Transactions
- Award
Common Stock
2022-05-31$1.09/sh+9,960$10,856→ 17,615 total
Footnotes (2)
- [F1]These shares were acquired under the Gemini Therapeutics, Inc. 2021 Employee Stock Purchase Plan ("ESPP").
- [F2]In accordance with the terms of the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 31, 2022.
Documents
Issuer
Gemini Therapeutics, Inc. /DE
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001815308
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 7:14 PM ET
- Size
- 5.0 KB